Patents for C12P 21 - Preparation of peptides or proteins (112,499)
01/2000
01/26/2000EP0973794A1 Netrin receptors
01/26/2000EP0973394A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF
01/26/2000EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
01/26/2000EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease
01/26/2000CN1048731C Polynucleotide of drug binding protein as coded CSAID
01/25/2000US6018032 A monoclonal antibody capable of binding to an epitope and neutralizing interleukin receptor; diagnosis and therapy for chronic bronchial asthma; antiasthmatic agent
01/25/2000US6018031 Binding agents specific for IgA receptor
01/25/2000US6018026 For rapid, inexpensive and adaptable high volume screening of ligands to receptors; for determining the presence of cell growth factors in samples; for purifying cell growth factors and isoforms
01/25/2000US6018024 A soluble fragment of amyloid protein having the carboxy terminal methionine or leucine amino acid resulting from cleavage of the intact protein; diagnosis and therapy for alzheimer's disease
01/25/2000US6018023 Kainate-binding, human CNS receptors of the EAA3 family
01/25/2000US6017885 IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling
01/25/2000US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase
01/25/2000US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon
01/25/2000US6017751 Process and composition for desizing cellulosic fabric with an enzyme hybrid
01/25/2000US6017743 Dna which codes for a glycosyltransferase which adds oligosialic acids to glycoproteins and glycolipids; for anticarcinogenic/antimetastasis/antiinflammatory agents; for maturation of sperm and reactivation of nervous tissues
01/25/2000US6017735 A fusion polypeptide having a herpes virus virion protein and a second protein selected from cell cycle control, suicide protein, antigenic sequences, immunomodulating or therapeutic protein; antiproliferative/anticarcinogenic agents
01/25/2000US6017729 Receptor activator of NF-κB
01/25/2000US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell
01/25/2000US6017717 Human thymosin β15 gene, protein and uses thereof
01/25/2000US6017714 Netrins
01/25/2000US6017695 A polynucleotide sequence that encodes a human brain glycoprotein, contactin; to study signal transmissions, cell morphology, cell metabolism and cell adhesion
01/25/2000US6017692 Methods of detecting a malignant cell in a biological sample comprising measuring Mxi gene expression alterations
01/25/2000US6017544 Isolating stress protein-peptide complex from tumor cells previously removed from a mammal and administering the isolated stress protein-peptide complex along with a cytokine to the mammal in order to stimulate an immune response
01/25/2000US6017542 Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor
01/25/2000US6017538 Plasmodium falciparum antigens inducing protective antibodies
01/25/2000CA2031504C Monoclonal antibodies to c-reactive protein
01/25/2000CA2027629C Glycopeptide antibiotics
01/25/2000CA1340880C Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins
01/25/2000CA1340879C Recombinant dna product and methods
01/25/2000CA1340878C Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies
01/20/2000WO2000003016A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain
01/20/2000WO2000003015A2 Human transport protein homologs
01/20/2000WO2000003012A2 Expression of eukaryotic peptides in plant plastids
01/20/2000WO2000003010A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon
01/20/2000WO2000003009A2 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use
01/20/2000WO2000003000A2 Serum-free medium for culturing animal cells
01/20/2000WO2000002925A1 Lupus anticoagulant antibody to f1 region of prothrombin
01/20/2000WO2000002924A1 Papillomavirus cellular receptor
01/20/2000WO2000002922A1 Antibody against protein tyrosine phosphatase intracellular domains
01/20/2000WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON)
01/20/2000WO2000002897A2 Delta cleavage products and methods based thereon
01/20/2000WO2000002587A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
01/20/2000WO1999059633A8 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
01/20/2000WO1999058641A8 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
01/20/2000WO1999051742A3 Dadd, death activator death domain protein
01/20/2000WO1999049037A3 Protein phosphatase-related molecules
01/20/2000WO1999047674A3 Compounds and methods for therapy and diagnosis of lung cancer
01/20/2000WO1999041386A3 Novel endo-xylogalacturonase
01/20/2000WO1999038964A3 Promoter regions of the mouse and human telomerase rna component genes
01/20/2000DE19932908A1 Bacillus genes for synthesis of anticapsin and bacilysine are useful as antagonists of glucosamine synthesis
01/20/2000CA2337101A1 Papillomavirus cellular receptor
01/20/2000CA2336710A1 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon
01/20/2000CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain
01/20/2000CA2334079A1 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use
01/20/2000CA2334078A1 Lupus anticoagulant antibody to f1 region of prothrombin
01/20/2000CA2333893A1 Delta cleavage products and methods based thereon
01/20/2000CA2333148A1 Expression of eukaryotic peptides in plant plastids
01/20/2000CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon)
01/20/2000CA2332307A1 Human transport protein homologs
01/20/2000CA2331789A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
01/19/2000EP0972837A2 Ubiquitin specific protease like protein
01/19/2000EP0972782A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
01/19/2000EP0972781A1 Proteins polypeptides and uses thereof
01/19/2000EP0972201A2 Compounds for immunodiagnosis of prostate cancer and methods for their use
01/19/2000EP0972198A1 Method for simultaneous detection of hiv antigens and hiv antibodies
01/19/2000EP0972059A1 Nucleic acid molecules encoding starch phosphorylase from maize
01/19/2000EP0972056A1 Reagents and methods useful for detecting diseases of the lung
01/19/2000EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
01/19/2000EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
01/19/2000EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof
01/19/2000EP0972040A1 Human gtp binding protein
01/19/2000EP0972038A1 Human tumorigenesis associated protein, htap
01/19/2000EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants
01/19/2000EP0972035A1 Human tumor suppressor
01/19/2000EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family
01/19/2000EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
01/19/2000EP0972026A2 Secreted proteins and polynucleotides encoding them
01/19/2000EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis
01/19/2000EP0972024A1 A tumor suppressor designated ts10q23.3
01/19/2000EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES
01/19/2000EP0971959A1 Humanized antibodies and methods for forming humanized antibodies
01/19/2000EP0971958A1 Method for purifying factor viii/vwf complex by cation-exchange chromatography
01/19/2000EP0971957A1 Polypeptide with appetite regulating activity
01/19/2000EP0971954A2 Secreted proteins and polynucleotides encoding them
01/19/2000EP0971951A1 Diagnosis of colorectal cancer and proteins and antibodies for use therein
01/19/2000EP0971950A2 Secreted proteins and polynucleotides encoding them
01/19/2000EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals
01/19/2000EP0625989B1 Dna sequences encoding novel growth/differentiation factors
01/19/2000EP0587873B1 Process for the production of cells infected by a multiple sclerosis associated virus
01/19/2000EP0552266B1 Preparation of chimaeric antibodies using the recombinant pcr strategy
01/19/2000EP0532587B1 Methods for trans-destabilization of specific proteins in vivo
01/19/2000CN1242053A Vaccines
01/19/2000CN1242052A Process for preparing purified dimer of bone-derived factor
01/19/2000CN1241901A Coat protein mediated resistance in plants
01/19/2000CN1241633A Gene engineering process of preparing spinach chloroplast triose phosphate isomerase
01/19/2000CN1241573A Liver cancer murine monoclone antibody without endogenous immunoglobulin and its preparation and application
01/19/2000CN1048523C Method for preparing viral protein generated from hepatitisvirokine
01/18/2000US6015938 Osteoprotegerin
01/18/2000US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins
01/18/2000US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents